Russell Investments Group
GLSI icon

Russell Investments Group’s Greenwich LifeSciences GLSI Stock Holding History

Russell Investments Group’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$954K Buy
39,697
+39,137
+6,989% +$1.02M ﹤0.01% 2235
2025
Q4 		$11.8K Sell
560
-89
-14% -$937 ﹤0.01% 3755
2025
Q3 		$6.46K Buy
649
+261
+67% +$2.95K ﹤0.01% 3857
2025
Q2 		$3.52K Buy
388
+220
+131% +$2.09K ﹤0.01% 3513
2025
Q1 		$1.6K Buy
+168
New +$2.04K ﹤0.01% 3548

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Russell Investments Group's GLSI Position: Q1 2026 in Review

Russell Investments Group increased its Greenwich LifeSciences (GLSI) stake by 6,989% in Q1 2026, buying an estimated $1.02M and bringing the position to 39,697 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Russell Investments Group first reported a position in GLSI in Q1 2025 and has held it in 5 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Russell Investments Group held 39,697 shares of Greenwich LifeSciences worth $954K as of Q1 2026.
  • Russell Investments Group bought 39,137 Greenwich LifeSciences shares in Q1 2026, an estimated $1.02M.
  • Greenwich LifeSciences made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2235 holding.
  • Russell Investments Group first reported a position in Greenwich LifeSciences in Q1 2025 and has held it in 5 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.